Advances in the treatment of psychiatric disorders in long-term care homes

Current Opinion in Psychiatry

Volumn 23, Issue 6, 2010, Pages 516-521

  Conn, David K ^a   Seitz, Dallas P ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

Dementia; depression; long term care; mental health; nursing home; psychiatric disorders; psychosocial interventions

Indexed keywords

ARIPIPRAZOLE; MELATONIN; OXCARBAZEPINE; PLACEBO; PRAZOSIN;

AGGRESSION; AGITATION; ALZHEIMER DISEASE; AROMATHERAPY; CLINICAL TRIAL; COCHRANE LIBRARY; COGNITIVE THERAPY; DEMENTIA; DEPRESSION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG WITHDRAWAL; EFFECT SIZE; HOME CARE; HUMAN; LONG TERM CARE; MEDLINE; META ANALYSIS; MUSIC; PHYSICAL ACTIVITY; PSYCHOSOCIAL ENVIRONMENT; PSYCHOTHERAPY; REVIEW; SLEEP WAKING CYCLE; SOMNOLENCE; STAFF TRAINING; SYSTEMATIC REVIEW;

AGED; ANTICONVULSANTS; ANTIPSYCHOTIC AGENTS; BEHAVIOR THERAPY; DEMENTIA; HOMES FOR THE AGED; HUMANS; MENTAL DISORDERS; NURSING HOMES; SOCIAL SUPPORT;

EID: 77958160465     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/YCO.0b013e32833efe56     Document Type: Review

References (41)

1. Seitz D, Purandare N, Conn D. Prevalence of psychiatric disorders among older adults in long-term care homes: a systematic review. Int Psychogeriatr 2010. [Epub ahead of print]
2. Stevenson DG, Decker SL, Dwyer LL, et al. Antipsychotic and benzodiazepine use among nursing home residents: findings from the 2004 National Nursing Home Survey. Am J Geriatr Psychiatry 2010. [Epub ahead of print]
3. Kamble P, Chen H, Sherer J, Aparasu RR. Antipsychotic drug use among elderly nursing home residents in the United States. Am J Geriatr Pharmacother 2008; 6:187-197.
4. Tucker M, Hosford I. Use of psychotropic medicines in residential care facilities for older people in Hawke's Bay, New Zealand. N Z Med J 2008; 121:18-25.
5. Conn DK, Ferguson I, Mandelman K, Ward C. Psychotropic drug utilization in long-term-care facilities for the elderly in Ontario, Canada. Int Psychogeriatr 1999; 11:223-233.
6. Seitz DP, Gruneir A, Conn DK, Rochon PA. Cholinesterase inhibitor use in U.S. nursing homes: results from the National Nursing Home Survey. J Am Geriatr Soc 2009; 57:2269-2274.
7. O'Connor DW, Ames D, Gardner B, King M. Psychosocial treatments of psychological symptoms in dementia: a systematic review of reports meeting quality standards. Int Psychogeriatr 2009; 21:241-251.
8. Kong EH, Evans LK, Guevara JP, et al. Nonpharmacological intervention for agitation in dementia: a systematic review and meta-analysis. Aging Ment Health 2009; 13:512-520.
9. Vernooij-Dassen M, Vasse E, Zuidema S, et al. Psychosocial interventions in dementia care in long tem care. Int Psychogeriatr 2010. [Epub ahead of print]
10. Bharucha AJ, Dew MA, Miller MD, et al. Psychotherapy in long term care: a review. J Am Med Dir Assoc 2006; 7:568-580.
11. Fleming R, Purandare N. Long term care for people with dementia: environmental design guidelines. Int Psychogeriatr 2010. [Epub ahead of print]
12. Livingston G, Johnston K, Katona C, et al., Old Age Task Force of the World Federation of Biological Psychiatry. Systematic review of psychological approaches to the management of neuropsychiatric symptoms of dementia. Am J Psychiatry 2005; 162:1996-2021.
13. Heyn P, Abreu BC, Ottenbacher KJ, et al. The effects of exercise training on elderly persons with cognitive impairment and dementia: a meta-analysis. Arch Phys Med Rehabil 2004; 85:1694-1704.
14. Kuske B, Hanns S, Luck T, et al. Nursing home staff training in dementia care: a systematic review of evaluated programs. Int Psychogeriatr 2007; 19:818-841.
15. Levy-Storms L. Therapeutic communication training in long term care institutions: recommendations for future research. Patient Educ Couns 2008; 73:8-21.
16. Vasse E, Vernooij-Dassen M, Spijker A, et al. A systematic review of communication strategies for people with dementia in residential and nursing homes. Int Psychogeriatr 2010; 22:189-200.
17. Deudon A, Maubourget N, Gervais X, et al. Nonpharmacological management of behavioral symptoms in nursing homes. Int J Geriatr Psychiatry 2009; 24:1386-1395.
18. Testad I, Ballard C, Bronnick K, Aarsland D. The effect of staff training on agitation and use of restraint in nursing home residents with dementia: a single-blind, randomized controlled trial. J Clin Psychiatry 2010; 71:80-86.
19. Chenoweth L, King MT, Jeon YH, et al. Caring for Aged Dementia Care Resident Study (CADRES) of person-centred care, dementia-care mapping, and usual care in dementia: a cluster-randomised trial. Lancet Neurol 2009; 4:317-325.
20. Cohen-Mansfield J, Marx MS, Dakheel-Ali M, et al. Can agitated behavior of nursing home residents with dementia be prevented with the use of standardized stimuli? J Am Geriatr Soc 2010. [Epub ahead of print]
21. Barrick AL, Sloane PD, Williams CS, et al. Impact of ambient bright light on agitation in dementia. Int J Geriatr Psychiatry 2010. [Epub ahead of print]
22. Lanctot KL, Herrmann N, Yau KK, et al. Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis. Can Med Assoc J 2003; 169:557-564.
23. Kaduszkiewicz H, Zimmermann T, Beck-Bornholdt HP, et al. Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials. BMJ 2005; 331:321-327.
24. Birks J. Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Syst Rev 2006; CD005593.
25. McShane R, Areosa Sastre A, Minakaran N. Memantine for dementia. Cochrane Database Syst Rev 2006:CD003154.
26. Winblad B, Jones RW, Wirth Y, et al. Memantine in moderate to severe Alzheimer's disease: a meta-analysis of randomised clinical trials. Dementia Geriatr Cog Dis 2007; 24:20-27.
27. Schneider LS, Pollock VE, Lyness SA. A metaanalysis of controlled trials of neuroleptic treatment in dementia. J Am Geriatr Soc 1990; 38:553-563.
28. Lonergan E, Luxenberg J, Colford J. Haloperidol for agitation in dementia. Cochrane Database Syst Rev (Online) 2002; CD002852.
29. Lanctot KL, Best TS, Mittmann N, et al. Efficacy and safety of neuroleptics in behavioral disorders associated with dementia. J Clin Psychiatry 1998; 59:550-561.
30. Schneider LS, Dagerman K, Insel PS. Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials. Am J Geriatr Psychiatry 2006; 14:191-210.
31. Ballard C, Waite J. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease. Cochrane Database Syst Rev 2006; CD003476.
32. Nelson JC, Delucchi K, Schneider LS. Efficacy of second generation antidepressants in late-life depression: a meta-analysis of the evidence. Am J Geriatr Psychiatry 2008; 16:558-567.
33. Mottram P, Wilson K, Strobl J. Antidepressants for depressed elderly. Cochrane Database Syst Rev 2006; CD003491.
34. Bains J, Birks JS, Dening TR. The efficacy of antidepressants in the treatment of depression in dementia. Cochrane Database Syst Rev 2002; CD003944.
35. Thompson S, Herrmann N, Rapoport MJ, et al. Efficacy and safety of antidepressants for treatment of depression in Alzheimer's disease: a metaanalysis. Can J Psychiatry 2007; 52:248-255.
36. Ruths S, Straand J, Nygaard HA, et al. Stopping antipsychotic drug therapy in demented nursing home patients: a randomized, placebo-controlled study: the Bergen District Nursing Home Study (BEDNURS). Int J Geriatr Psychiatry 2008; 23:889-895.
37. Streim JE, Porsteinsson AP, Breder CD, et al. A randomized, double-blind, placebo-controlled study of aripiprazole for the treatment of psychosis in nursing home patients with Alzheimer disease. Am J Geriatr Psychiatry 2008; 16:537-550.
38. Sommer OH, Aga O, Cvancarova M, et al. Effect of oxcarbazepine in the treatment of agitation and aggression in severe dementia. Dement Geriatr Cogn Disord 2009; 27:155-163.
39. Wang LY, Shofer JB, Rohde K, et al. Prazosin for the treatment of behavioral symptoms in patients with Alzheimer disease with agitation and aggression. Am J Geriatr Psychiatry 2009; 17:744-751.
40. Gehrman PR, Connor DJ, Martin JL, et al. Melatonin fails to improve sleep or agitation in double-blind randomized placebo-controlled trial of institutionalized patients with Alzheimer disease. Am J Geriatr Psychiatry 2009; 17:166-169.
41. Snowdon J. Mental health service delivery in long-term care homes. Int Psychogeriatr 2010. [Epub ahead of print]